By now you've heard the news. On Tuesday, April 13, the U.S. Centers for Disease Control and Food and Drug Administration cited six reports of patients...
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this...
Denmark Permanently Bans AstraZeneca Jab Over Blood Clots As EU Tops 100M Vaccinations As the US's decision to discontinue the Johnson & Johnson vaccine provokes a...
With changing recommendations about AstraZeneca's COVID-19 vaccine making headlines, many people have questions about its use.
Remember back in February, when we were worried about a market correction? Back when the NASDAQ dipped 10% from its peak…
Although the industry still relies on transient transfection, due to the difficulty of creating stable production cell lines, a shift from adherent to suspension culture is...
The field test, called NIRVANA, can simultaneously detect and sequence SARS-CoV-2, influenza and other viruses Credit: Mo Li/KAUST LA JOLLA–(March 31, 2021) Clinicians using a new...
Reaction To COVID-19 Vaccine Caused Man's Skin To Peel Off: Doctors Authored by Zachary Stieber via The Epoch Times, A reaction to Johnson & Johnson’s COVID-19...
AstraZeneca just announced results from its US-based trial. It found the vaccine to be 79% effective and safe for use, despite recent concerns around reports of...
Ocugen (OCGN) has been one of 2021’s biggest and unlikeliest success stories. The eye disease specialist has shifted its focus to getting another Covid-19 vaccine to market.\
Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the...
Top EU Regulator Insists AstraZeneca Jab Is Safe While 24 Countries Have Banned It During a press conference on Tuesday, Europe's top medical regulator, the European...
Norway Investigates Whether AstraZeneca Vaccine Caused Deadly Blood Clots Update (1124ET): As the first AstraZeneca shots arrive in South America via the WHO's Covax program, the...
With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the EMA was forced into starting rolling review of...
In this roundtable discussion, four experts from academia and industry met to discuss challenges in refining and scaling up AAV production pipelines to meet the increasing...
How Does The J&J Vaccine Compare To Other COVID Vaccines? 4 Questions Answered Authored by Yves Smith via NakedCapitalism.com, We are running this post for one...
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, The post FDA clears third emergency COVID-19 vaccine...
Friday the FDA Advisory Panel voted unanimously (22-0) to endorse the (one-shot, no mRNA) J&J.
A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson’s one-dose COVID-19 vaccine on Friday, setting...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Altimmune is among the biotechs trying to find more convenient delivery alternatives for COVID-19 vaccines
A transcript of The Conversation Weekly podcast episode #3.
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Britain launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc are combined in a...
Both vaccines appear to reduce the risk of developing COVID-19, and so could be approved later this year.
Russia's "Sputnik V" Vaccine 92% Effective Against "Symptomatic" COVID Cases As it turns out, the Kremlin wasn't embellishing when it first said its COVID vaccine, developed...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response